Guardion Health Sciences, Inc.
GHSI
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.11% | -96.88% | |||
| Total Other Revenue | -- | -76.20% | |||
| Total Revenue | -10.11% | -97.24% | |||
| Cost of Revenue | -17.19% | -97.21% | |||
| Gross Profit | -1.89% | -97.26% | |||
| SG&A Expenses | -2.17% | -29.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.62% | -59.23% | |||
| Operating Income | 2.18% | -101.96% | |||
| Income Before Tax | 53.57% | -1,181.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 53.57% | -1,181.78% | |||
| Earnings from Discontinued Operations | 8,268.79% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 317.50% | -1,217.66% | |||
| EBIT | 2.18% | -101.96% | |||
| EBITDA | 2.17% | -102.71% | |||
| EPS Basic | 316.86% | -1,203.06% | |||
| Normalized Basic EPS | 53.98% | -757.41% | |||
| EPS Diluted | 316.86% | -1,203.06% | |||
| Normalized Diluted EPS | 53.98% | -757.41% | |||
| Average Basic Shares Outstanding | 0.30% | 1.32% | |||
| Average Diluted Shares Outstanding | 0.30% | 1.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
